Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
New York Times
NYT
$10.3B
| $14M | 0.03% |
919,600
+65,750
| +8% | +$1.03M |
|
|
CLDT
652
Chatham Lodging
CLDT
$601M
| $14M | 0.03% |
637,846
+292,394
| +85% | +$6.34M |
|
653
Strategic Education
STRA
$1.86B
| $14M | 0.03% |
265,700
+60,762
| +30% | +$3.07M |
|
654
Pinnacle West Capital
PNW
$12.2B
| $13.9M | 0.03% |
240,900
-433,100
| -64% | -$24M |
|
655
LXP Industrial Trust
LXP
$3.58B
| $13.9M | 0.03% |
252,696
+136,055
| +117% | +$7.54M |
|
|
WWE
656
DELISTED
World Wrestling Entertainment
WWE
| $13.9M | 0.03% |
1,164,900
-812,600
| -41% | -$13.4M |
|
|
EEP
657
DELISTED
Enbridge Energy Partners
EEP
| $13.9M | 0.03% |
376,100
-539,731
| -59% | -$16.6M |
|
658
Comstock Resources
CRK
$3.99B
| $13.9M | 0.03% |
96,280
-44,280
| -32% | -$5.83M |
|
659
FMC
FMC
$1.27B
| $13.8M | 0.03% |
224,259
+199,585
| +809% | +$13.1M |
|
|
TA
660
DELISTED
TravelCenters of America LLC
TA
| $13.8M | 0.03% |
311,680
+21,545
| +7% | +$860K |
|
661
Gilead Sciences
GILD
$171B
| $13.8M | 0.03% |
166,648
-22,705
| -12% | -$1.77M |
|
|
OAK
662
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $13.8M | 0.03% |
275,170
+250,886
| +1,033% | +$13M |
|
|
DRIV
663
DELISTED
DIGITAL RIVER INC.
DRIV
| $13.7M | 0.03% |
890,966
+347,400
| +64% | +$5.53M |
|
664
News Corp Class A
NWSA
$15.6B
| $13.7M | 0.03% |
765,398
+29,346
| +4% | +$507K |
|
665
White Mountains Insurance
WTM
$5.11B
| $13.7M | 0.03% |
22,493
-807
| -3% | -$481K |
|
666
Emergent Biosolutions
EBS
$230M
| $13.6M | 0.03% |
607,511
-155,387
| -20% | -$3.62M |
|
|
PLCM
667
DELISTED
POLYCOM INC
PLCM
| $13.6M | 0.03% |
1,086,821
+430,508
| +66% | +$5.46M |
|
|
CERN
668
DELISTED
Cerner Corp
CERN
| $13.6M | 0.03% |
263,704
+92,104
| +54% | +$4.84M |
|
669
Waterstone Financial
WSBF
$385M
| $13.6M | 0.03% |
1,190,241
+439,442
| +59% | +$4.71M |
|
|
BID
670
DELISTED
Sotheby's
BID
| $13.6M | 0.03% |
323,200
-355,400
| -52% | -$14.5M |
|
671
Olin
OLN
$2.17B
| $13.5M | 0.03% |
502,900
-365,100
| -42% | -$10.1M |
|
672
Avient
AVNT
$4.23B
| $13.5M | 0.03% |
320,958
+55,722
| +21% | +$2.18M |
|
|
RAX
673
DELISTED
Rackspace Hosting Inc
RAX
| $13.5M | 0.03% |
+400,900
| New | +$13.3M |
|
|
GLOG
674
DELISTED
GASLOG LTD
GLOG
| $13.5M | 0.03% |
423,000
+175,500
| +71% | +$4.6M |
|
675
Mesa Laboratories
MLAB
$633M
| $13.5M | 0.03% |
160,600
+26,457
| +20% | +$2.19M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.